Founded in 2010, Pharmazz operates in Health Tech offering novel products in critical care medicine. The company has developed Centhaquine for hypovolemic shock and Sovateltide for cerebral ischemic s...
Funding stage:
Corporate Round
Last funding:
22/05/2025
Total funding:
$45.82 Mn+
Revenue:
Investors
Employee count:
42
Last 90d
42
Last 90d
Web traffic:
1.95K
1.95K
Last 30d
Last 30d
Glassdoor Rating:
Pharmazz: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders77
Latest Filing Date30 March 2024- Funding Events34
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Pharmazz
As of 31 March 2024, Pharmazz's equity is held by 76 shareholders, with the top three being Pharmazz, Sidhant Rakyan, and Manish Gupta.
Pharmazz holds the largest stake in Pharmazz at 152.0% as of 31 March 2024.
As of 31 March 2024, founders collectively hold 5.4% equity in Pharmazz.
As of 31 March 2024, investors collectively hold 38.4% equity in Pharmazz.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links